InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the complete record of transactions filed by Buell Jennifer, Chief Executive Officer. Insider active across 2 companies, notably MiNK Therapeutics, Inc.. Cumulatively, 6 filings have been recorded. The latest transaction was disclosed on 2 January 2026 — Retenue fiscale. Regulator: SEC (Form 4). All data is openly available.
Declarations6 total
US$94,86210,024 shares@ US$9.463557.5% of flow
Common Stock
SEC:0001193125-26-012914·
€94,86210,024 shares@ €9.46350.18% mcap28.7% of flow
Common Stock
SEC:0001193125-26-012914:0·
US$70,2335,351 shares@ US$13.125142.5% of flow
Common Stock
SEC:0001193125-25-230098·
€70,2335,351 shares@ €13.12510.13% mcap21.3% of flow
Common Stock
SEC:0001193125-25-230098:0·
€49,06710,597 shares@ €4.63030.033% mcap100.0% of flow
Common Stock
SEC:0000899243-21-027356·
€49,06710,597 shares@ €4.63030.033% mcap50.0% of flow
Common Stock
SEC:0000899243-21-027356:0·
6 of 6 declarations
About Buell Jennifer
Jennifer Buell is the Chief Executive Officer and President at MiNK Therapeutics, Inc. and AGENUS INC. She leads the strategic operations of these companies, focusing on the development of immunological therapies. Her experience in the biopharmaceutical sector is a significant asset in achieving growth objectives.
